- Home
- NSIT vs PCVX Comparison
NSIT vs PCVX Comparison
Compare NSIT & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NSIT
- PCVX
- Stock Information
- Founded
- NSIT 1988
- PCVX 2013
- Country
- NSIT United States
- PCVX United States
- Employees
- NSIT N/A
- PCVX N/A
- Industry
- NSIT EDP Services
- PCVX Biotechnology: Pharmaceutical Preparations
- Sector
- NSIT Technology
- PCVX Health Care
- Exchange
- NSIT Nasdaq
- PCVX Nasdaq
- Market Cap
- NSIT 3.4B
- PCVX 4.0B
- IPO Year
- NSIT 1995
- PCVX 2020
- Fundamental
- Price
- NSIT $103.67
- PCVX $43.52
- Analyst Decision
- NSIT Buy
- PCVX Strong Buy
- Analyst Count
- NSIT 3
- PCVX 8
- Target Price
- NSIT $183.00
- PCVX $114.17
- AVG Volume (30 Days)
- NSIT 341.0K
- PCVX 1.8M
- Earning Date
- NSIT 10-30-2025
- PCVX 11-05-2025
- Dividend Yield
- NSIT N/A
- PCVX N/A
- EPS Growth
- NSIT N/A
- PCVX N/A
- EPS
- NSIT 4.21
- PCVX N/A
- Revenue
- NSIT $8,355,589,000.00
- PCVX N/A
- Revenue This Year
- NSIT $0.41
- PCVX N/A
- Revenue Next Year
- NSIT $4.96
- PCVX N/A
- P/E Ratio
- NSIT $24.94
- PCVX N/A
- Revenue Growth
- NSIT N/A
- PCVX N/A
- 52 Week Low
- NSIT $104.25
- PCVX $27.66
- 52 Week High
- NSIT $212.68
- PCVX $116.00
- Technical
- Relative Strength Index (RSI)
- NSIT 30.20
- PCVX 65.42
- Support Level
- NSIT $104.25
- PCVX $41.24
- Resistance Level
- NSIT $111.54
- PCVX $45.50
- Average True Range (ATR)
- NSIT 2.46
- PCVX 1.61
- MACD
- NSIT 0.26
- PCVX -0.16
- Stochastic Oscillator
- NSIT 11.17
- PCVX 70.19
About NSIT Insight Enterprises Inc.
Insight Enterprises Inc is a Fortune IT provider engaged in helping businesses of all sizes, large enterprises, governments, schools, and healthcare organizations. The company has three geographic operating segments: North America, EMEA, and APAC. It generates maximum revenue from the North America segment. The company provides digital innovation, cloud/data center transformation, connected workforce, and supply chain optimization solutions and services.
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.